Home › Funds › Tri Locum Partners LP › AXSM
Tri Locum Partners LP position in AXSM
AXSOME THERAPEUTICS INC. · Health Care
Tri Locum Partners LP reported holding 143,338 shares of AXSM (AXSOME THERAPEUTICS INC.) in its Q3 2026 13F filing — a position valued at US$26.4M, representing 5.22% of its reported portfolio and ranking #9 among its reported holdings. Tri Locum Partners LP has disclosed AXSM holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Tri Locum Partners LP's AXSM position evolved
Tri Locum Partners LP first disclosed a stake in AXSM in Q3 2023 at 142,510 shares (US$10.0M). The position peaked in Q2 2026 at 219,308 shares, worth US$53.7M. Across 13 filings, Tri Locum Partners LP increased the stake 5 time(s), trimmed it 7 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 143,338 shares valued at US$26.4M — a reduction of -75,970 shares quarter over quarter.. Notable position changes include a 198% increase in Q2 2024 (shares rose 12% over the following quarter), a 172% increase in Q4 2024 (shares rose 38% over the following quarter), a 253% increase in Q2 2026 (shares fell 25% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 142.51K | $9.96M | New |
| Q4 2023 | 130.74K | $10.41M | Reduce |
| Q1 2024 | 102.71K | $8.20M | Reduce |
| Q2 2024 | 306.51K | $24.67M | Add |
| Q3 2024 | 91.72K | $8.24M | Reduce |
| Q4 2024 | 249.77K | $21.13M | Add |
| Q1 2025 | 101.24K | $11.81M | Reduce |
| Q2 2025 | 157.86K | $16.48M | Add |
| Q3 2025 | 292.14K | $35.48M | Add |
| Q4 2025 | 201.63K | $36.83M | Reduce |
| Q1 2026 | 62.12K | $10.50M | Reduce |
| Q2 2026 | 219.31K | $53.68M | Add |
| Q3 2026 | 143.34K | $26.43M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About AXSM and 13F data
AXSM (AXSOME THERAPEUTICS INC.) is a Health Care company. 43 other funds we track also report a position in AXSM — the largest reported positions include Deep Track Capital, LP (US$147.5M), ALETHEA CAPITAL MANAGEMENT, LLC (US$119.7M), Sofinnova Investments, Inc. (US$82.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AXSM
- Deep Track Capital, LP 800.00K sh · $147.51M · Q3 2026
- ALETHEA CAPITAL MANAGEMENT, LLC 649.12K sh · $119.69M · Q3 2026
- Sofinnova Investments, Inc. 445.91K sh · $82.22M · Q3 2026
- FRONTIER CAPITAL MANAGEMENT CO LLC 254.28K sh · $62.24M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 300.10K sh · $55.34M · Q3 2026
- SAMLYN CAPITAL, LLC 289.25K sh · $53.33M · Q3 2026
More on Tri Locum Partners LP
FAQ
How long has Tri Locum Partners LP held AXSM?
Tri Locum Partners LP has disclosed AXSM holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Tri Locum Partners LP's current position in AXSM?
As of Q3 2026, Tri Locum Partners LP holds 143.34K shares of AXSM (AXSOME THERAPEUTICS INC.), valued at $26.43M, representing 5.22% of its reported portfolio and ranking #9.
Has Tri Locum Partners LP been buying or selling AXSM?
In the latest 13F filing (Q3 2026), Tri Locum Partners LP reduced its position in AXSM. The position peaked in Q2 2026 at 219.31K shares.
Which other funds hold AXSM?
Other major institutional holders of AXSM include Deep Track Capital, LP, ALETHEA CAPITAL MANAGEMENT, LLC, Sofinnova Investments, Inc., among 43 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.